Increased capillary branching contributes to angiotensin type 1 receptor blocker (ARB) - Induced regression of sclerosis

American Journal of Pathology

Volumn 178, Issue 4, 2011, Pages 1891-1898

  Scruggs, Benjamin S ^a   Zuo, Yiqin ^a   Donnert, Ellen ^a   Ma, Lijun ^a   Bertram, John F ^b   Fogo, Agnes B ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; GLOMERULUS CAPILLARY; GRAPH THEORY; MALE; NEPHRECTOMY; NEPHROSCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; REMISSION; THEORY; THREE DIMENSIONAL IMAGING;

EID: 79953657126     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.12.029     Document Type: Article

References (24)

1. Fogo AB: Can glomerulosclerosis be reversed? Nat Clin Pract Nephrol 2006, 2:290-291
2. Fogo AB: Progression versus regression of chronic kidney disease. Nephrol Dial Transplant 2006, 21:281-284
3. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M: Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998, 339:69-75 (Pubitemid 28304880)
4. Ma LJ, Nakamura S, Aldigier JC, Rossini M, Yang H, Liang X, Nakamura I, Marcantoni C, Fogo AB: Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1. J Am Soc Nephrol 2005, 16:966-976 (Pubitemid 41710307)
5. Fujihara CK, Velho M, Malheiros DM, Zatz R: An extremely high dose of losartan affords superior renoprotection in the remnant model. Kidney Int 2005, 67:1913-1924 (Pubitemid 40577727)
6. Ikoma M, Kawamura T, Kakinuma Y, Fogo A, Ichikawa I: Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions. Kidney Int 1991, 40:195-202
7. Remuzzi A, Gagliardini E, Sangalli F, Bonomelli M, Piccinelli M, Benigni A, Remuzzi G: ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal disease. Kidney Int 2006, 69:1124-1130
8. Boffa JJ, Lu Y, Placier S, Stefanski A, Dussaule JC, Chatziantoniou C: Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases. J Am Soc Nephrol 2003, 14:1132-1144 (Pubitemid 36514656)
9. Adamczak M, Gross ML, Krtil J, Koch A, Tyralla K, Amann K, Ritz E: Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats. J Am Soc Nephrol 2003, 14:2833-2842 (Pubitemid 37305646)
10. Adamczak M, Gross ML, Amann K, Ritz E: Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature. J Am Soc Nephrol 2004, 15:3063-3072 (Pubitemid 39578838)
11. Zoja C, Corna D, Camozzi D, Cattaneo D, Rottoli D, Batani C, Zanchi C, Abbate M, Remuzzi G: How to fully protect the kidney in a severe model of progressive nephropathy: a multidrug approach. J Am Soc Nephrol 2002, 13:2898-2908 (Pubitemid 35386909)
12. Fogo AB: New capillary growth: a contributor to regression of sclerosis? Curr Opin Nephrol Hypertens 2005, 14:201-203
13. Eddy AA, Fogo AB: Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action. J Am Soc Nephrol 2006, 11:2999-3012 (Pubitemid 44707760)
14. Liang XB, Ma LJ, Naito T, Wang Y, Madaio M, Zent R, Pozzi A, Fogo AB: Angiotensin type 1 receptor blocker restores podocyte potential to promote glomerular endothelial cell growth. J Am Soc Nephrol 2006, 17:1886-1895 (Pubitemid 44036173)
15. Yoshida Y, Fogo A, Ichikawa I: Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis. Kidney Int 1989, 35:654-660 (Pubitemid 19051766)
16. Yoshida Y, Kawamura T, Ikoma M, Fogo A, Ichikawa I: Effects of antihypertensive drugs on glomerular morphology. Kidney Int 1989, 36:626-635 (Pubitemid 19239554)
17. Piecha G, Koleganova N, Gross ML, Geldyyev A, Adamczak M, Ritz E: Regression of glomerulosclerosis in subtotally nephrectomized rats: effects of monotherapy with losartan, spironolactone, and their combination. Am J Physiol Renal Physiol 2008, 295:F137-144
18. Marinides GN, Groggel GC, Cohen AH, Border WA: Enalapril and low protein reverse chronic puromycin aminonucleoside nephropathy. Kidney Int 1990, 37:749-757 (Pubitemid 20056848)
19. SebekovÁ K, Lill M, Boor P, Heidland A, Amann K: Functional and partial morphological regression of established renal injury in the obese Zucker rat by blockade of the renin-angiotensin system. Am J Nephrol 2008, 29:164-170
20. Aldigier JC, Kanjanbuch T, Ma LJ, Brown NJ, Fogo AB: Regression of existing glomerulosclerosis by inhibition of aldosterone. J Am Soc Nephrol 2005, 16:3306-3314 (Pubitemid 46187550)
21. Bacallao RL, Yu W, Dunn KW, Phillips CL: Novel light microscopy imaging techniques in nephrology. Curr Opin Nephrol Hypertens 2003, 12:455-461 (Pubitemid 36871869)
22. Wahl EM, Quintas LV, Lurie LL, Gargano ML: A graph theory analysis of renal glomerular microvascular networks. Microvasc Res 2004, 67:223-230 (Pubitemid 38581876)
23. Phillips CL, Gattone VH 2nd, Bonsib SM: Imaging glomeruli in renal biopsy specimens. Nephron Physiol 2006, 103:75-81
24. Marx M, Daniel TO, Kashgarian M, Madri JA: Spatial organization of the extracellular matrix modulates the expression of PDGF-receptor subunits in mesangial cells. Kidney Int 1993, 43:1027-1041 (Pubitemid 23137087)